EXPLORING EFFECTIVENESS OF LOW LEVEL LASER THERAPY IN THE TREATMENT OF PATIENTS WITH BELLS PALSY (NCT07191808) | Clinical Trial Compass
By InvitationNot Applicable
EXPLORING EFFECTIVENESS OF LOW LEVEL LASER THERAPY IN THE TREATMENT OF PATIENTS WITH BELLS PALSY
Pakistan100 participantsStarted 2025-10
Plain-language summary
The aim of the proposed research is to explore effectiveness of Low Level LASER Therapy in the country and to compare its effectiveness with routine physiotherapy. The societal benefit of submitted research is to formulate a guideline for physical therapy clinicians of the country to treat patients with Bell's Palsy through modern tool of Low Level LASER Therapy if found effective for improvement in quality of lives
Who can participate
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* • A confirmed diagnosis of idiopathic facial (Bell's) palsy by a certified neurologist or Physician is required (Heckmann, Urban, Pitz, Guntinas-Lichius, \& Gágyor, 2019).
* Both male and female patients, aged between 18 and 80 years (Holland \& Bernstein, 2014).
* Symptom onset within the range of 72 hours to 7 days (Petruzzelli \& Hirsch, 1991).
* A baseline House-Brackmann score of 2 to 4 is necessary (Bylund et al., 2021).
* Availability for the entire trial duration and all subsequent follow-up visits.
* Absence of any prior treatments (e.g., corticosteroids) for the current Bell's palsy episode.
Exclusion Criteria:
* • Alternate diagnoses that can explain Bell's palsy (e.g., Lyme disease, Ramsay Hunt syndrome) (Crouch, Hohman, Moody, \& Andaloro, 2023).
* History of recurrent Bell's palsy episodes.
* Presence of severe medical conditions such as uncontrolled diabetes or autoimmune disorders.
* Pregnancy or lactation. Use of concurrent medications that could interfere with facial nerve function.
* Exposure to LLLT in the past 3 months.
* Active skin infections or lesions in the targeted treatment area.
* Conditions or medications that induce photosensitivity.
* Cognitive impairments that may interfere with comprehension or feedback about the trial.
* Participation in another trial in the past month.
* Traumatic, inflammatory, or infectious conditions including trauma, nerve root issues, metabolic/spinal pathologies, …